Position in BIIB
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$292,761
-$755,703 QoQ
Shares Held
1,355
-76.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#680
of 1,036 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Essential Partners LLC holds $4,144,626 across 14 Drug Manufacturers - General names. BIIB ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
10,044 | $1,290,654 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
17,545 | $1,010,942 | |
| 3 | JNJ |
Johnson & Johnson
|
2,596 | $659,306 | |
| 4 | LLY |
ELI LILLY & Co
|
371 | $444,988 | |
| 5 | BIIB |
Biogen Inc.
This page
|
1,355 | $292,761 | |
| 6 | PFE |
Pfizer Inc
|
10,101 | $243,232 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
515 | $65,065 | |
| 8 | NVS |
Novartis AG
|
320 | $50,150 |
All Filings in BIIB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $292,761 | 1,355 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,048,464 | 5,719 | Shares | Sole | 2026-05-21 | |
| 2025-12-31 | $1,005,606 | 5,714 | Shares | Sole | 2026-05-21 | |
| 2025-09-30 | $778,704 | 5,559 | Shares | Sole | 2026-05-21 | |
| 2025-06-30 | $671,278 | 5,345 | Shares | Sole | 2026-05-21 | |
| No filing history on record for this holder in this stock. | ||||||